Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
AEterna Zentaris to Present at Upcoming CIBC World Markets 7th Annual Eastern Investor Conference
Date:9/17/2008
QUEBEC CITY, Sept. 17 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its Senior Vice President and Chief Financial Officer, Dennis Turpin, CA, will present a company overview at the upcoming CIBC World Markets 7th Annual Eastern Investor Conference on Tuesday, September 23, 2008 at 3:25 pm (eastern time), at the Centre Sheraton Hotel in Montreal, Canada.
A live webcast of the presentation will be available on AEterna Zentaris' website at http://www.aezsinc.com in the Investors section. A replay will also be available for a period of 30 days on the Company's website.
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at http://www.aezsinc.com.
'/>"/>
| SOURCE AETERNA ZENTARIS INC. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. AEterna Zentaris Reports Second Quarter 2008 Financial and Operating Results
2. AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
3. AEterna Zentaris to Announce Second Quarter 2008 Financial and Operating Results on August 12, 2008
4. AEterna Zentaris Sells Quebec City Building for $7.1 million
5. AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting
6. AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal
7. AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
8. AEterna Zentaris to Announce First Quarter 2008 Financial and Operating Results and Hold Annual Shareholder Meeting on May 7, 2008
9. AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan
10. AEterna Zentaris Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
11. AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia
Post Your Comments:
(Date:7/26/2017)... KENILWORTH, N.J. , July 26, 2017 Nurse practitioners ... according to the findings of a Merck Manuals survey ... a recent medical conference, revealed that most (88 percent) believe ... on diagnoses, treatments and prescriptions. ... Merck Manuals survey of ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... Charm Sciences, ... been accepted by the National Conference on Interstate Milk Shipments (NCIMS) Laboratory Committee and ... Program, set to launch July 1, 2017. , The NCIMS voted at its annual ...
(Date:7/20/2017)... ... July 20, 2017 , ... The Arnold ... Elihu Thomson Professor of Electrical Engineering and Computer Science at the Massachusetts Institute ... annually, the award recognizes an individual who has made and is continuing to ...
(Date:7/20/2017)... ... July 20, 2017 , ... VIC Technology Venture Development™ ... company’s board of directors. This addition continues to strengthen and diversify VIC’s board. ... CEO and Chairman. “He is a highly accomplished business executive with a broad range ...
Breaking Biology Technology:[0] Merck Manuals Survey: 88 Percent of Nurse Practitioners Spend at Least Half of Appointment Times on Patient Education[0] Tetracycline Safe Level Test Approved for NCIMS Appendix N Pilot Program[0] Beckman Foundation Names Dr. James G. Fujimoto of the Massachusetts Institute of Technology as 2017 Beckman-Argyros Vision Research Award Winner[0] James B. (Jamie) Rogers Joins VIC Technology Venture Development™ Board of Directors
(Date:6/23/2017)... and ITHACA, N.Y. , June ... Cornell University, a leader in dairy research, today announced ... designed to help reduce the chances that the global ... onset of this dairy project, Cornell University has become ... Sequencing the Food Supply Chain, a food safety initiative ...
(Date:5/6/2017)... -- RAM Group , Singaporean based technology ... biometric authentication based on a novel quantum-state ... perform biometric authentication. These new sensors are based on a ... Group and its partners. This sensor will have widespread ... security. Ram Group is a next generation sensor ...
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
Breaking Biology News(10 mins):[0] IBM Research and Cornell University to Use Genetic Sequencing and Big Data Analytics to Help Keep Global Milk Supply Safe[8] Ram Group Announces World's First Full-Body Biometric Authentication Technology[2] Emerging 3D Printing and Smart Manufacturing Technologies featured at UBM's Annual Advanced Design and Manufacturing Event in New York
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |